April 25-26,2019Day one morning-Global Industry trends
Day one afternoon to Day two
Stream A-- Drug Substance
Stream B-- Formulation Design and development
Stream C-- Analytical Development and Support
Stream D-- Regulatory Planning Session
Stream E-- BE Studies Session
Shandong BestcommPharmaceutical Co., Ltd.
Shandong BestcommPharmaceutical Co., Ltd. was established in August 2000, which is engaged in R&D ofnew pharmaceutical products. It is the first enterprise of its kind in China obtainedthe Certificate of Conformity of Quality Management System Certification (ISO9001:2008) and passed the Intellectual Property Management System certification(GB/T 29490-2013), it has won a number of honorary certificates such as the"National Technology Transfer Demonstration Institution", "FirstTop Ten Technology Transfer Institutions in Shandong Province". In March2016, it was officially listed on National Equities Exchange and Quotations(NEEQ) under the stock code 836534.
The company currently is staffed with more than 400 R&Demployees and equipped with more than 100 high-performance liquidchromatography systems. Over 330 new pharmaceutical products have beensuccessfully developed and over 210 products have been granted “New Drug Certificate”or “Drug Registration Approval”, additionally over 60 patents and trademarks havebeen granted. Now, it has established long-term stable cooperativerelationships with more than 200 pharmaceutical enterprises including more than40 of Top 100 enterprises of Chinese Pharmaceutical Industry and more than 50listed companies.
We will continue to be guided by the "Integrity,Innovation, Cooperation and Win-Win" principle to create more value forour customers, and carry out the noble mission of “Defense of people’s health” togetherwith outstanding enterprises.